Adachi K, Aoyagi T, Iizuka H, Halprin K M, Levin V
Curr Probl Dermatol. 1980;10:39-65. doi: 10.1159/000396281.
A great deal of knowledge has been gained concerning the activation of adenylate and guanylate cyclase in epidermal cells. Adenylate cyclase is activated by 4 different independent receptors-responding respectively to catecholamine (beta), to prostaglandins (E), to histamine (H2), and to adenosine and it phosphorylated derivatives. Upon activation, each of these receptors becomes unresponsive to further stimulation by its specific stimulator. Guanylate cyclase, on the other hand, is activated by histamine (H1) and epidermal growth factor (EGF). Unlike EGF, the histamine activation is extremely rapid (less than 5 minutes). Epidermal cells are permeable (leak) to cyclic GMP but not cyclic AMP. When the skin is traumatized or injured in any way (even by intradermal injection) there is a sudden catastrophic change in the intracellular levels of the cyclic nucleotides (and of ATP). Cyclic AMP rapidly rises to perhaps 5-10 times its normal resting level while cyclic GMP falls to 10-20% of its level in vivo. The rise in cyclic AMP is due to activation of adenylate cyclase while the fall in cyclic GMP is due in major part to activation of cyclic GMP phosphodiesterase (and perhaps the fall in ATP is due to activation of ATPase). The changes in ATP and cyclic AMP can be reversed by incubating the tissue in a buffered salt solution containing glucose, but this does not normalize the cyclic GMP content. The fall in cyclic GMP can be prevented by a phosphodiesterase inhibitor (IBMX ). This series of events has been called the "ischemia effect." However, it implies that a lack of oxygen is at fault, and that has not been shown to be the case. Its underlying cause and possible physiologic significance are not known. Do these changes in cyclic nucleotides have effects on epidermal proliferation? And does EGF? Agents which increase cyclic AMP do inhibit the epidermal outgrowth and mitotic activity of explant cultures of pig skin. Cyclic GMP does increase outgrowth at a particular concentration. Histamine, which elevates both cyclic nucleotides, has a biphasic action depending on its concentration. These findings imply that these nucleotides do act as one of the controls of epidermal proliferation. The action of cyclic GMP is not accompanied by detectably increased phosphorylation of epidermal proteins. On the other hand, EGF action which also enhances epidermal outgrowth is characterized by an increased protein phosphorylation that precedes any increase in cellular cyclic GMP. We conclude that the action of EGF is independent of the cyclic nucleotide system.
关于表皮细胞中腺苷酸环化酶和鸟苷酸环化酶的激活,人们已经获得了大量知识。腺苷酸环化酶由4种不同的独立受体激活,它们分别对儿茶酚胺(β)、前列腺素(E)、组胺(H2)以及腺苷及其磷酸化衍生物作出反应。激活后,这些受体中的每一个对其特定刺激物的进一步刺激都不再有反应。另一方面,鸟苷酸环化酶由组胺(H1)和表皮生长因子(EGF)激活。与表皮生长因子不同,组胺的激活极其迅速(不到5分钟)。表皮细胞对环鸟苷酸可渗透(渗漏),但对环腺苷酸不渗透。当皮肤受到任何形式的创伤或损伤(即使是皮内注射)时,环核苷酸(以及ATP)的细胞内水平会突然发生灾难性变化。环腺苷酸迅速上升至其正常静息水平的5 - 10倍,而环鸟苷酸降至其体内水平的10 - 20%。环腺苷酸的升高是由于腺苷酸环化酶的激活,而环鸟苷酸的下降主要是由于环鸟苷酸磷酸二酯酶的激活(也许ATP的下降是由于ATP酶的激活)。通过将组织置于含有葡萄糖的缓冲盐溶液中孵育,ATP和环腺苷酸的变化可以逆转,但这并不能使环鸟苷酸含量恢复正常。环鸟苷酸的下降可以被磷酸二酯酶抑制剂(异丁基甲基黄嘌呤)阻止。这一系列事件被称为“缺血效应”。然而,这意味着缺氧是原因,但尚未证明情况确实如此。其根本原因和可能的生理意义尚不清楚。这些环核苷酸的变化对表皮增殖有影响吗?表皮生长因子呢?增加环腺苷酸的试剂确实会抑制猪皮肤外植体培养物的表皮生长和有丝分裂活性。环鸟苷酸在特定浓度下确实会增加生长。组胺会使两种环核苷酸都升高,其作用取决于浓度,具有双相性。这些发现表明,这些核苷酸确实作为表皮增殖的控制因素之一发挥作用。环鸟苷酸的作用并未伴随着表皮蛋白磷酸化的可检测增加。另一方面,表皮生长因子的作用也会增强表皮生长,其特征是在细胞内环鸟苷酸增加之前蛋白质磷酸化增加。我们得出结论,表皮生长因子的作用独立于环核苷酸系统。